Ohio State appoints leader of blood and marrow transplant, cellular therapy programs
Click Here to Manage Email Alerts
Marcos J. de Lima, MD, has been appointed to key leadership positions at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
He will serve as leader of the blood and marrow transplant and cellular therapy programs. He also will serve as professor in the division of hematology, as well as a member of the cancer center’s leukemia research program.
“I firmly believe that Ohio State has it all: forward-thinking leadership, resources, commitment and willingness to bring forth new treatments to patients,” de Lima said in a press release. “My vision to create a multidisciplinary engine of cellular therapy development and production has found a home.”
Before joining Ohio State, de Lima served as co-leader of the hematopoietic and immune cancer biology program at Case Comprehensive Cancer Center, as well as director of the hematologic malignancies and stem cell transplant program at University Hospitals Seidman Cancer Center.
“We are thrilled to have Dr. de Lima join the OSUCCC — James team,” Raphael E. Pollock, MD, PhD, FACS, director of the comprehensive cancer center and surgical oncologist at The James Cancer Hospital and Solove Research Institute, said in the release. “His vision and expertise will help us move our cellular therapy and research program to even greater levels.”
In his new role, de Lima will be responsible for building an internal cellular therapy product development program.
“There has been tremendous progress in cellular therapy for cancer, but we are just scratching the surface,” de Lima said. “We have ambitious goals for expanding clinical trials to develop new and refine existing cellular therapy approaches with the potential to move from conceptualization and testing in OSUCCC — James laboratories to the clinical bedside to help patients. I’m excited to join such a strong team and look forward to us achieving even greater things together — all for the benefit of patients impacted by cancer.”
Click Here to Manage Email Alerts